CABOTEGRAVIR (Apretude) Nursing Considerations

What is the generic name?

CABOTEGRAVIR

What is the Trade Name for CABOTEGRAVIR?

Apretude

What are the Indications for CABOTEGRAVIR?

• 1 INDICATIONS AND USAGE APRETUDE is indicated in at-risk adults and adolescents weighing at least 35 kg for pre‚Äëexposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test prior to initiating APRETUDE (with or without an oral lead-in with oral cabotegravir) for HIV-1 PrEP [see Dosage and Administration ( 2.2 , 2.4 ), Contraindications ( 4 ), Warnings and Precautions ( 5.1 )] . APRETUDE is an HIV-1 integrase strand transfer inhibitor (INSTI) indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test prior to initiating APRETUDE (with or without an oral lead-in with oral cabotegravir) for HIV-1 PrEP. ( 1 )

References: https://open.fda.gov/